title: Caffeine can be used for oocyte enucleation.
abstract: The removal of chromosomes from recipient oocytes is one of the key steps in nuclear transfer cloning. Although microtubule interrupters have been successfully used for oocyte enucleation, their potential side effect on oocyte developmental potential should be considered, and less harmful drugs should be explored for chemical-assisted enucleation. Based on our previous findings that any maturation promoting factor-activating agent induces ooplasmic protrusion without disrupting microtubules, we have studied the feasibility to use caffeine or MG132 for chemical-assisted enucleation. Experiments using goat oocytes showed that treatments for 30 min with 1-mM caffeine or 5-μM MG132-induced ooplasmic protrusions in about 85% of the oocytes, a percentage similar to that achieved with optimal demecolcine treatment. Rates of enucleation, cell fusion and in vitro blastulation were similar among caffeine, MG132, and demecolcine enucleation but significantly higher than blind aspiration. Furthermore, neither rates of pregnancy on days 90 and 120 nor the general rate of live births/embryos transferred differed significantly (p > 0.05) between caffeine and demecolcine enucleation. Although oocytes treated with caffeine did not retract protrusions until 2 h, many oocytes treated with MG132 withdrew protrusions as early as 0.5 h after treatment. The optimal treatment to induce ooplasmic protrusion in 75% pig oocytes was 8-mM caffeine for 60 min. Mouse oocytes responded poorly to demecolcine or caffeine with less than 40% forming inconspicuous protrusions following optimal treatments. It is concluded that caffeine can be used for enucleation of goat and pig oocytes with similar results as demecolcine, and live kids were born after caffeine-assisted enucleation.
authors: College of Animal Science and Veterinary Medicine, Shandong Agricultural University, Tai-an City, People's Republic of China.
authors: Hui-Li
authors: HL
authors: Wang
authors: Zhong-Le
authors: ZL
authors: Chang
authors: Kun-Liang
authors: KL
authors: Li
authors: Hua-Yu
authors: HY
authors: Lian
authors: Dong
authors: D
authors: Han
authors: Wei
authors: W
authors: Cui
authors: Guang-Zhong
authors: GZ
authors: Jiao
authors: Yan-Guang
authors: YG
authors: Wu
authors: Ming-Jiu
authors: MJ
authors: Luo
authors: Jing-He
authors: JH
authors: Tan
mesh_terms: D000818:Animals; D002110:Caffeine / Q000494:pharmacology*; D002467:Cell Nucleus / Q000187:drug effects*; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology; D003703:Demecolcine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006041:Goats; D007976:Leupeptins / Q000494:pharmacology; D051379:Mice; D008870:Microtubules / Q000187:drug effects; D023421:Models, Animal; D053652:Nuclear Transfer Techniques; D009865:Oocytes / Q000166:cytology* / Q000187:drug effects*; D011247:Pregnancy; D018873:Pregnancy Rate; D013552:Swine; D050257:Tubulin Modulators / Q000494:pharmacology
chemical_list: D015853:Cysteine Proteinase Inhibitors; D007976:Leupeptins; D050257:Tubulin Modulators; D002110:Caffeine; C072553:benzyloxycarbonylleucyl-leucyl-leucine aldehyde; D003703:Demecolcine